wanghaibo
wanghaibo
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Different Doses of Dalpicicl Combined With Letrozole in the First-line Treatment of HR-positive, HER2-negative Advanced Breast Cancer | HR Positive HER2 Negative Advanced Breast Cancer | Recruiting | Phase 2 | 2025-12-16 | NCT07285382 |